A novel genomic approach to elucidate the cause and clinical implications of reduced von Willebrand factor levels

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

12 Downloads (Pure)

Original language	English
Pages (from-to)	2406-2409
Number of pages	4
Journal	Journal of Thrombosis and Haemostasis
Volume	23
Issue number	8
DOIs	https://doi.org/10.1016/j.jtha.2025.05.010
Publication status	Published - Aug 2025

Access to Document

@article{15668f1c4a684468b3614e638a927905,

title = "A novel genomic approach to elucidate the cause and clinical implications of reduced von Willebrand factor levels",

author = "Ferdows Atiq",

year = "2025",

month = aug,

doi = "10.1016/j.jtha.2025.05.010",

language = "English",

volume = "23",

pages = "2406--2409",

journal = "Journal of Thrombosis and Haemostasis",

issn = "1538-7933",

publisher = "Elsevier",

number = "8",

}

TY - JOUR

T1 - A novel genomic approach to elucidate the cause and clinical implications of reduced von Willebrand factor levels

AU - Atiq, Ferdows

PY - 2025/8

Y1 - 2025/8

UR - https://www.scopus.com/pages/publications/105012030593

U2 - 10.1016/j.jtha.2025.05.010

DO - 10.1016/j.jtha.2025.05.010

M3 - Comment/Letter to the editor

C2 - 40738589

AN - SCOPUS:105012030593

SN - 1538-7933

VL - 23

SP - 2406

EP - 2409

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

IS - 8

ER -